A study performed in mice has uncovered a potential new tool to combat the escalating issue of childhood obesity.
AbbVie and Umoja to develop new CAR-T therapies for cancer
Share this article Under the initial deal, AbbVie will obtain a sole licensing option for CD19-directed in-situ generated CAR-T cell therapy candidates of Umoja. Credit: